about
Ganoderma lucidum(Reishi mushroom) for cancer treatmentGanoderma lucidum(Reishi mushroom) for cancer treatmentNatural killer activity in a medium-term multi-organ bioassay for carcinogenesisMassage therapy research reviewExploratory study on the ayurvedic therapeutic management of cerebral palsy in children at a tertiary care hospital of karnataka, India.Inhibition of human NK cell function by valinomycin, a toxin from Streptomyces griseus in indoor airAntiviral and antitumor peptides from insects.Dysregulated expression of both the costimulatory CD28 and inhibitory CTLA-4 molecules in PB T cells of advanced cervical cancer patients suggests systemic immunosuppression related to disease progressionBiobehavioral outcomes following psychological interventions for cancer patients.Cancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.Effect of a 12-week walking exercise program on body composition and immune cell count in patients with breast cancer who are undergoing chemotherapy.Individual trajectories in stress covary with immunity during recovery from cancer diagnosis and treatmentsAlterations in the Th1/Th2 balance in breast cancer patients using reflexology and scalp massage.Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival.The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancerNatural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapyNeutrophils in antibody-based immunotherapy of cancer.Ex vivo generation of highly purified and activated natural killer cells from human peripheral blood.Blood transfusion promotes cancer progression: a critical role for aged erythrocytes.Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses.Physical Activity in Breast Cancer Patients during Medical Treatment and in the Aftercare - a Review.Significant impairment in immune recovery after cancer treatment.Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.NK cells: key to success of DC-based cancer vaccines?Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.Regional anaesthesia and cancer metastases: the implication of local anaesthetics.Fruit Polyphenols: A Review of Anti-inflammatory Effects in Humans.Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy.The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: an updated meta-analysis.Antitumor activity and underlying mechanisms of ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice.Transduction of KAI1/CD82 cDNA promotes hematogenous spread of human lung-cancer cells in natural killer cell-depleted SCID mice.HLA class II antibodies recruit G-CSF activated neutrophils for treatment of B cell malignancies.Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha1-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity.Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition.Immunomodulatory Polysaccharide from Chlorophytum borivilianum Roots.Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
P2860
Q24185921-1F175442-A10E-4B4D-8682-584C1F449742Q24202814-EFA1FFC2-6A50-4F6D-A1AF-5BFF1EA445C4Q28371719-B7232DF1-4193-4CBD-91E8-D532C2665A35Q30846591-984F6966-3E8E-4699-A18E-A1AB3D7CD38CQ33657648-911BC832-B3CC-4CD5-A0DF-32CFC09D7EE6Q34003002-A50ED5CE-EB32-44A7-ACD9-C0DD30F9C083Q34188871-592BC663-17DE-42B2-9B10-00FB26149B88Q34633776-4E8A5C97-E8EF-407B-A5AC-B044C4ADA24DQ34713718-6E4CBD9D-F297-4FC3-BB8E-A57DCA3E29C7Q35800595-D6E70A3C-6066-4575-923F-B4C28B60769AQ36218640-B6BB656A-2786-4A5D-B29D-B413D081510EQ36294840-063EA37A-D1CD-433A-AB70-35D966F72BB6Q36375332-CC045AB8-06A4-4AC6-B46D-22D771EF2E15Q36566943-DF4B4485-3F99-49FF-A6EC-EE9703B8282FQ36621650-56675492-8871-4DCB-A4FA-AE1D6EF69677Q36621686-D4DE65C1-663A-46C3-B8E6-4F218D4298EAQ36645866-4F2402DB-247B-4490-91C2-DF0D65D5E9D8Q36652214-7380CF3D-EB3E-47A1-961E-78A2824870FDQ36673566-D75B2234-099B-44ED-892B-C54278A205DBQ36719911-7E0B4C72-7BFC-42BC-96C8-38C9924FDA2BQ37032641-8D11E6D4-869D-430D-97F6-A24DC9A5A535Q37122377-C9CCE5FB-F27A-4E93-9B00-A7577A6C02F0Q37223763-0B206364-828B-460D-94AD-AF1C12BA9BF0Q37342761-64628900-C488-4E36-ACA4-BB705CB099C5Q37389283-E83E04A0-E251-4908-9361-FA2BD7006D23Q37421739-CF049152-9962-46DA-A178-82D7B96B3743Q37879601-4B30E2B6-4631-4837-A41B-D46A1FF67E4FQ38036202-2CB85F68-15B5-4625-9CF1-EC7655866289Q38074885-39BC61D0-F5F3-4E97-B2FF-4E1AB359DC6AQ38153450-1BD4DF3B-1BE6-4563-BFF1-A5A9E34EDC3AQ38330344-476AD901-1FE7-495B-BF29-D7CB3F1EB15AQ39143305-656784D5-4B12-46D1-8397-E9E01341953AQ39966103-6684D405-B4CC-4908-ADF6-E86238482F32Q40416233-2F568755-54A8-4002-A2A6-B64DE38A2EF8Q40773477-F3906BF4-CA1D-41D0-810C-9B833BE859BAQ40887973-EEEB8BC8-7314-42D9-B389-C8D6F1694F8BQ40971735-D0A1E0C5-5BEA-4297-8667-AF24FC15E7F4Q41711976-DB647D66-7898-4FF2-861E-306C99573992Q42014417-6BFB841C-1713-4F18-9D07-8C5E57080C69Q42286093-3697A418-DB19-4581-BB6C-CEACBBDB13D2
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Natural killer cells and cancer.
@en
type
label
Natural killer cells and cancer.
@en
prefLabel
Natural killer cells and cancer.
@en
P2093
P2860
P1433
P1476
Natural killer cells and cancer.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G
P407
P577
1996-04-01T00:00:00Z